Adverse Obstetric and Perinatal Outcomes following Treatment of Adolescent and Young Adult Cancer: A Population-Based Cohort Study

被引:68
作者
Haggar, Fatima A. [1 ,2 ]
Pereira, Gavin [3 ,4 ]
Preen, David [2 ]
Holman, C. D'Arcy [2 ]
Einarsdottir, Kristjana [3 ]
机构
[1] Univ Ottawa, Ottawa Hosp Res Inst, Dept Surg, Ottawa, ON, Canada
[2] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA 6009, Australia
[3] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia
[4] Yale Univ, Sch Med, Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT USA
基金
澳大利亚国家健康与医学研究理事会;
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CHILDHOOD-CANCER; PREGNANCY OUTCOMES; REPRODUCTIVE OUTCOMES; PLACENTAL ABRUPTION; FEMALE SURVIVORS; PRETERM BIRTH; WILMS-TUMOR; FERTILITY;
D O I
10.1371/journal.pone.0113292
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: To investigate obstetric and perinatal outcomes among female survivors of adolescent and young adult (AYA) cancers and their offspring. Methods: Using multivariate analysis of statewide linked data, outcomes of all first completed pregnancies (n=1894) in female survivors of AYA cancer diagnosed in Western Australia during the period 1982-2007 were compared with those among females with no cancer history. Comparison pregnancies were matched by maternal age-group, parity and year of delivery. Results: Compared with the non-cancer group, female survivors of AYA cancer had an increased risk of threatened abortion (adjusted relative risk 2.09, 95% confidence interval 1.51-2.74), gestational diabetes (2.65, 2.08-3.57), pre-eclampsia (1.32, 1.04-1.87), post-partum hemorrhage (2.83, 1.92-4.67), cesarean delivery (2.62, 2.22-3.04), and maternal postpartum hospitalization >5 days (3.01, 1.72-5.58), but no excess risk of threatened preterm delivery, antepartum hemorrhage, premature rupture of membranes, failure of labor to progress or retained placenta. Their offspring had an increased risk of premature birth (<37 weeks: 1.68, 1.21-2.08), low birth weight (<2500 g: 1.51, 1.23-2.12), fetal growth restriction (3.27, 2.45-4.56), and neonatal distress indicated by low Apgar score (<7) at 1 minute (2.83, 2.28-3.56), need for resuscitation (1.66, 1.27-2.19) or special care nursery admission (1.44, 1.13-1.78). Congenital abnormalities and perinatal deaths (intrauterine or <= 7 days of birth) were not increased among offspring of survivors. Conclusion: Female survivors of AYA cancer have moderate excess risks of adverse obstetric and perinatal outcomes arising from subsequent pregnancies that may require additional surveillance or intervention.
引用
收藏
页数:16
相关论文
共 57 条
[1]   Placental abruption and perinatal mortality in the United States [J].
Ananth, CV ;
Wilcox, AJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (04) :332-337
[2]   Placental abruption and adverse perinatal outcomes [J].
Ananth, CV ;
Berkowitz, GS ;
Savitz, DA ;
Lapinski, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1646-1651
[3]  
Apgar V, CURR RES ANESTH ANAL, V1, P260
[4]  
*AUSTR BUR STAT, 2010, BIRTHS AUSTR 2009
[5]  
Australian Bureau of Statistics, 2006, DROP
[6]   Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study [J].
Baker, K. Scott ;
Ness, Kirsten K. ;
Steinberger, Julia ;
Carter, Andrea ;
Francisco, Liton ;
Burns, Linda J. ;
Sklar, Charles ;
Forman, Stephen ;
Weisdorf, Daniel ;
Gurney, James G. ;
Bhatia, Smita .
BLOOD, 2007, 109 (04) :1765-1772
[7]   Adolescents, Young Adults, and Cancer-the International Challenge [J].
Barr, Ronald D. .
CANCER, 2011, 117 (10) :2245-2249
[8]   Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound [J].
Bath, LE ;
Wallace, WHB ;
Shaw, MP ;
Fitzpatrick, C ;
Anderson, RA .
HUMAN REPRODUCTION, 2003, 18 (11) :2368-2374
[9]  
Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO
[10]  
2-2